Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy, safety and tolerability of BMS-986368 in participants with multiple sclerosis-associated spasticity; recruitment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• BMS-986368

Snippet

Sponsor: Celgene | Conditions: Multiple Sclerosis Spasticity | Phase 2 | Status: RECRUITING